These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 35784362
1. Humanized Anti-RGMa Antibody Treatment Promotes Repair of Blood-Spinal Cord Barrier Under Autoimmune Encephalomyelitis in Mice. Hirata T, Itokazu T, Sasaki A, Sugihara F, Yamashita T. Front Immunol; 2022; 13():870126. PubMed ID: 35784362 [Abstract] [Full Text] [Related]
2. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis. Zhang L, Tang S, Ma Y, Liu J, Monnier P, Li H, Zhang R, Yu G, Zhang M, Li Y, Feng J, Qin X. Front Immunol; 2022; 13():861486. PubMed ID: 35664003 [Abstract] [Full Text] [Related]
6. Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis. Tanabe S, Fujita Y, Ikuma K, Yamashita T. Cell Death Dis; 2018 Oct 17; 9(11):1061. PubMed ID: 30333477 [Abstract] [Full Text] [Related]
7. Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models. Huang L, Fung E, Bose S, Popp A, Böser P, Memmott J, Kutskova YA, Miller R, Tarcsa E, Klein C, Veldman GM, Mueller BK, Cui YF. Neurobiol Dis; 2021 Nov 17; 159():105492. PubMed ID: 34478849 [Abstract] [Full Text] [Related]
20. Multiparametric magnetic resonance imaging for detection of pathological changes in the central nervous system of a mouse model of multiple sclerosis in vivo. Althobity AA, Khan N, Sandrock CJ, Woodruff TM, Cowin GJ, Brereton IM, Kurniawan ND. NMR Biomed; 2023 Oct 27; 36(10):e4964. PubMed ID: 37122101 [Abstract] [Full Text] [Related] Page: [Next] [New Search]